PATENT CLAIM ANALYSIS

Application Number: 16285762
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "274000"]

Abstract:
There is provided a compound of formula (I) which is an inhibitor of the family of p38 mitogen-activated protein kinase enzymes, and to its use in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, including inflammatory diseases of the lung, such as asthma and COPD.

Claim (Index 10):
A compound of formula (I) according to any of  claims 1  to  7  or a pharmaceutical composition according to  claim 8  for use in the treatment or prevention of exacerbations in patients which chronic respiratory disease, such as COPD (including chronic bronchitis and emphysema), asthma, paediatric asthma, cystic fibrosis, sarcoidosis, idiopathic pulmonary fibrosis.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 99.0
- Lexical Diversity: 1.425
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14795957', '14349345', '15812425', '15925384', '15636730']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7984950439020373
- 35 USC 102 Novelty (BERT): 0.6091696267014753
- Combined Prediction Score: 0.7795625021819812
- Mean Citation Score: 452.28391400000015
- Max Citation Score: 575.10077
- Similarity Product: 454.44171191446014

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test